Pages that link to "Q114081687"

The following pages link to Barry D. Kahan (Q114081687):

Displaying 11 items.

• Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin (Q28568866) (← links)
• Long-term outcomes of single paediatric vs. ideal adult renal allograft transplants in adult recipients (Q36536747) (← links)
• Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts (Q36739635) (← links)
• Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients (Q36889289) (← links)
• The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities (Q40370385) (← links)
• Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals. (Q41472065) (← links)
• Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation (Q43145488) (← links)
• Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity (Q43211236) (← links)
• Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation (Q44419288) (← links)
• The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function (Q44536893) (← links)
• Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines (Q45124321) (← links)